Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2026-02-02 @ 11:45 AM
Study NCT ID:
NCT02664961
Status:
TERMINATED
Last Update Posted:
2019-07-23
First Post:
2016-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Sponsor:
Tracon Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-20
First Submit QC Date:
None
Study First Post Date:
2016-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-16
Results First Submit QC Date:
None
Results First Post Date:
2019-06-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-09
Last Update Post Date:
2019-07-23
Last Update Post Date Type:
ACTUAL